Traynor Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.16M Sell
6,098
-428
-7% -$81.3K 0.08% 82
2025
Q1
$1.37M Buy
6,526
+215
+3% +$45K 0.12% 78
2024
Q4
$1.12M Buy
6,311
+686
+12% +$122K 0.07% 85
2024
Q3
$1.11M Buy
5,625
+837
+17% +$165K 0.07% 90
2024
Q2
$821K Buy
4,788
+476
+11% +$81.6K 0.06% 93
2024
Q1
$785K Buy
4,312
+198
+5% +$36.1K 0.07% 102
2023
Q4
$638K Buy
4,114
+322
+8% +$49.9K 0.07% 111
2023
Q3
$565K Sell
3,792
-378
-9% -$56.4K 0.07% 108
2023
Q2
$562K Buy
4,170
+22
+0.5% +$2.96K 0.07% 113
2023
Q1
$661K Buy
4,148
+552
+15% +$88K 0.1% 104
2022
Q4
$581K Buy
3,596
+173
+5% +$28K 0.08% 114
2022
Q3
$459K Buy
3,423
+252
+8% +$33.8K 0.08% 100
2022
Q2
$485K Sell
3,171
-735
-19% -$112K 0.08% 97
2022
Q1
$633K Buy
3,906
+6
+0.2% +$972 0.08% 101
2021
Q4
$528K Sell
3,900
-360
-8% -$48.7K 0.06% 126
2021
Q3
$459K Buy
4,260
+426
+11% +$45.9K 0.06% 123
2021
Q2
$441K Buy
3,834
+171
+5% +$19.7K 0.06% 120
2021
Q1
$396K Buy
3,663
+858
+31% +$92.8K 0.07% 115
2020
Q4
$300K Sell
2,805
-1,869
-40% -$200K 0.05% 119
2020
Q3
$394K Buy
4,674
+50
+1% +$4.22K 0.09% 103
2020
Q2
$454K Buy
4,624
+449
+11% +$44.1K 0.11% 95
2020
Q1
$318K Sell
4,175
-1,520
-27% -$116K 0.11% 89
2019
Q4
$504K Buy
5,695
+194
+4% +$17.2K 0.13% 96
2019
Q3
$416K Buy
5,501
+451
+9% +$34.1K 0.13% 103
2019
Q2
$370K Sell
5,050
-1,228
-20% -$90K 0.12% 106
2019
Q1
$505K Sell
6,278
-352
-5% -$28.3K 0.17% 89
2018
Q4
$611K Buy
6,630
+887
+15% +$81.7K 0.25% 65
2018
Q3
$543K Buy
5,743
+577
+11% +$54.6K 0.18% 84
2018
Q2
$480K Sell
5,166
-1,137
-18% -$106K 0.18% 87
2018
Q1
$596K Buy
6,303
+1,164
+23% +$110K 0.24% 72
2017
Q4
$497K Buy
5,139
+61
+1% +$5.9K 0.21% 87
2017
Q3
$451K Buy
5,078
+130
+3% +$11.5K 0.21% 90
2017
Q2
$355K Sell
4,948
-1,668
-25% -$120K 0.18% 107
2017
Q1
$499K Buy
+6,616
New +$499K 0.28% 74
2016
Q4
Sell
-3,345
Closed -$205K 131
2016
Q3
$205K Buy
+3,345
New +$205K 0.14% 113